The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Advances in the Biofabrication of 3D Skin in vitro: Healthy and Pathological Models
Open accessAbstract
The relevance for in vitro three-dimensional (3D) tissue culture of skin has been present for almost a century. From using skin biopsies in organ culture, to vascularized organotypic full-thickness reconstructed human skin equivalents, in vitro tissue regeneration of 3D skin has reached a golden era. However, the reconstruction of 3D skin still has room to grow and develop. The need for reproducible methodology, physiological structures and tissue architecture, and perfusable vasculature are only recently becoming a reality, though the addition of more complex structures such as glands and tactile corpuscles require advanced technologies. In this review, we will discuss the current methodology for biofabrication of 3D skin models and highlight the advantages and disadvantages of the existing systems as well as emphasize how new techniques can aid in the production of a truly physiologically relevant skin construct for preclinical innovation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
25th Anniversary Article: Engineering Hydrogels for Biofabrication
Malda, J., Visser, J., Melchels, F. P., Jüngst, T., Hennink, W. E., Dhert, W. J. A., Groll, J., & Hutmacher, D. W. (2013) · Advanced Materials · doi:10.1002/adma.201302042 · Cited by 1,901
Modeling physiological events in 2D vs. 3D cell culture
Duval, K., Grover, H., Han, L.-H., Mou, Y., Pegoraro, A. F., Fredberg, J., & Chen, Z. (2017) · Physiology · doi:10.1152/physiol.00036.2016 · Cited by 1,849 · cited 1×
“Although these 2D cell culture systems have played a key role in furthering our understanding of molecular signaling, cellular morphology, and drug discovery, not all results and conclusions from these 2D cell culture systems are translatable to physiological in vivo systems (Duval et al., 2017; Langhans, 2018).”
BackgroundHay, R. J., Johns, N. E., Williams, H. C., Bolliger, I. W., Dellavalle, R. P., Margolis, D. J., Marks, R., Naldi, L., Weinstock, M. A., Wulf, S. K., et al. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.446 · Cited by 1,706 · cited 1×
“The predominant types of skin diseases include fungal diseases, subcutaneous diseases, acne vulgaris, pruritus, eczema, impetigo, molluscum contagiosum/warts, and scabies (Hay et al., 2014).”
BackgroundMulticellular tumor spheroids: An underestimated tool is catching up again
Hirschhaeuser, F., Menne, H., Dittfeld, C., West, J., Mueller-Klieser, W., & Kunz-Schughart, L. A. (2010) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2010.01.012 · Cited by 1,674
Collagen-based biomaterials for wound healing
Chattopadhyay, S., & Raines, R. T. (2014) · Biopolymers · doi:10.1002/bip.22486 · Cited by 1,041
Hydrogel bioprinted microchannel networks for vascularization of tissue engineering constructs
Bertassoni, L. E., Cecconi, M., Manoharan, V., Nikkhah, M., Hjortnaes, J., Cristino, A. L., Barabaschi, G., Demarchi, D., Dokmeci, M. R., Yang, Y., et al. (2014) · Lab Chip · doi:10.1039/c4lc00030g · Cited by 944
Antoine, E. E., Vlachos, P. P., & Rylander, M. N. (2014) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2014.0086 · Cited by 611
Hoarau-Véchot, J., Rafii, A., Touboul, C., & Pasquier, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010181 · Cited by 489
Human Skin 3D Bioprinting Using Scaffold‐Free Approach
Pourchet, L. J., Thepot, A., Albouy, M., Courtial, E. J., Boher, A., Blum, L. J., & Marquette, C. A. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201601101 · Cited by 352
Multi-cell type human liver microtissues for hepatotoxicity testing
Messner, S., Agarkova, I., Moritz, W., & Kelm, J. M. (2013) · Archives of Toxicology · doi:10.1007/s00204-012-0968-2 · Cited by 319
Tissue Engineering Approaches in the Design of Healthy and Pathological In Vitro Tissue Models
Caddeo, S., Boffito, M., & Sartori, S. (2017) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2017.00040 · Cited by 285
Bioengineering Dermo-Epidermal Skin Grafts with Blood and Lymphatic Capillaries
Marino, D., Luginbühl, J., Scola, S., Meuli, M., & Reichmann, E. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3006894 · Cited by 242
Itoh, M., Umegaki-Arao, N., Guo, Z., Liu, L., Higgins, C. A., & Christiano, A. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077673 · Cited by 239
Dermal Matrices and Bioengineered Skin Substitutes: A Critical Review of Current Options
Debels, H., Hamdi, M., Abberton, K., & Morrison, W. (2015) · Plastic and Reconstructive Surgery Global Open · doi:10.1097/gox.0000000000000219 · Cited by 227
Hair Follicle Development in Mouse Pluripotent Stem Cell-Derived Skin Organoids
Lee, J., Bӧscke, R., Tang, P.-C., Hartman, B. H., Heller, S., & Koehler, K. R. (2018) · Cell Reports · doi:10.1016/j.celrep.2017.12.007 · Cited by 187
Vörsmann, H., Groeber, F., Walles, H., Busch, S., Beissert, S., Walczak, H., & Kulms, D. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.249 · Cited by 168
Gledhill, K., Guo, Z., Umegaki-Arao, N., Higgins, C. A., Itoh, M., & Christiano, A. M. (2015) · PLOS ONE · doi:10.1371/journal.pone.0136713 · Cited by 132
Animal models of skin disease for drug discovery
Avci, P., Sadasivam, M., Gupta, A., De Melo, W. C., Huang, Y.-Y., Yin, R., Chandran, R., Kumar, R., Otufowora, A., Nyame, T., et al. (2013) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2013.761202 · Cited by 130 · cited 1×
“Currently, the primary means of identifying therapeutics for these diseases require the use of animal models (Avci et al., 2013), increasing not only the cost of drug development, but also the cost for consumers.”
BackgroundBioengineering a 3D integumentary organ system from iPS cells using an in vivo transplantation model
Takagi, R., Ishimaru, J., Sugawara, A., Toyoshima, K.-E., Ishida, K., Ogawa, M., Sakakibara, K., Asakawa, K., Kashiwakura, A., Oshima, M., et al. (2016) · Science Advances · doi:10.1126/sciadv.1500887 · Cited by 107
Stojadinovic, O., Yin, N., Lehmann, J., Pastar, I., Kirsner, R. S., & Tomic-Canic, M. (2013) · Immunologic Research · doi:10.1007/s12026-013-8474-z · Cited by 88
Cited by
Wound healing, fibroblast heterogeneity, and fibrosis
Talbott, H. E., Mascharak, S., Griffin, M., Wan, D. C., & Longaker, M. T. (2022) · Cell Stem Cell · doi:10.1016/j.stem.2022.07.006 · Cited by 795
Challenges in exploring and manipulating the human skin microbiome
Boxberger, M., Cenizo, V., Cassir, N., & La Scola, B. (2021) · Microbiome · doi:10.1186/s40168-021-01062-5 · Cited by 247
Dijkhoff, I. M., Drasler, B., Karakocak, B. B., Petri-Fink, A., Valacchi, G., Eeman, M., & Rothen-Rutishauser, B. (2020) · Particle and Fibre Toxicology · doi:10.1186/s12989-020-00366-y · Cited by 202
Modelling the Complexity of Human Skin In Vitro
Hofmann, E., Schwarz, A., Fink, J., Kamolz, L.-P., & Kotzbeck, P. (2023) · Biomedicines · doi:10.3390/biomedicines11030794 · Cited by 129
Biofabrication of human skin with its appendages
Hosseini, M., Koehler, K. R., & Shafiee, A. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202201626 · Cited by 102
Metadata
- Authors
- Randall, M. J., Jüngel, A., Rimann, M., & Wuertz-Kozak, K.
- Venue
- Frontiers in Bioengineering and Biotechnology
- Publisher
- Frontiers Media SA
- Published
- 2018-10-31
- Volume
- 6
- Pages
- 154-154
- ISSN
- 2296-4185 (ISSN-L)
- OpenAlex
- W2899101138
- Cited by
- 194
- References
- 20
- FWCI
- 5.19
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.